Global clinical trial reveals safest, most effective antibiotics for golden staph bloodstream infections

An international clinical trial has identified the optimal antibiotics for golden staph bloodstream infections, a breakthrough set to reshape treatment for the life-threatening condition. The SNAP Trial found that the standard antibiotic, flucloxacillin, should no longer be the drug of choice for treating the infection, revealing that cefazolin and benzylpenicillin offer safer and equally effective alternatives for patients.